🎉 M&A multiples are live!
Check it out!

Ebos Group Valuation Multiples

Discover revenue and EBITDA valuation multiples for Ebos Group and similar public comparables like D1000 Varejo Farma, Brasil Pharma, and SC Ropharma.

Ebos Group Overview

About Ebos Group

Ebos is the second-largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government’s Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.


Founded

1922

HQ

New Zealand
Employees

5.8K+

Website

ebosgroup.com

Sectors

Pharmacies

Financials

LTM Revenue $9.1B

LTM EBITDA $435M

EV

$4.2B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Ebos Group Financials

As of September 2025, Ebos Group reported last 12-month revenue of $9.1B and EBITDA of $435M.

In the same period, Ebos Group generated $828M in LTM gross profit and $190M in net income.

See Ebos Group valuation multiples based on analyst estimates

Ebos Group P&L

In the most recent fiscal year, Ebos Group reported revenue of $7.6B and EBITDA of $331M.

Ebos Group expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Ebos Group valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $9.1B XXX $7.6B XXX XXX XXX
Gross Profit $828M XXX $1.0B XXX XXX XXX
Gross Margin 9% XXX 13% XXX XXX XXX
EBITDA $435M XXX $331M XXX XXX XXX
EBITDA Margin 5% XXX 4% XXX XXX XXX
EBIT $339M XXX $260M XXX XXX XXX
EBIT Margin 4% XXX 3% XXX XXX XXX
Net Profit $190M XXX $132M XXX XXX XXX
Net Margin 2% XXX 2% XXX XXX XXX
Net Debt XXX XXX $565M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Ebos Group Stock Performance

Ebos Group has current market cap of NZD 5.8B (or $3.3B), and EV of NZD 7.4B (or $4.2B).

Market Cap Evolution

Ebos Group Stock Data

As of October 20, 2025, Ebos Group's stock price is NZD 29 (or $16).

See Ebos Group trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$4.2B $3.3B XXX XXX XXX XXX $0.84

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Ebos Group Valuation Multiples

Ebos Group's trades at 0.5x EV/Revenue multiple, and 12.0x EV/EBITDA.

See valuation multiples for Ebos Group and 15K+ public comps

Ebos Group Financial Valuation Multiples

As of October 20, 2025, Ebos Group has market cap of $3.3B and EV of $4.2B.

Equity research analysts estimate Ebos Group's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Ebos Group has a P/E ratio of 20.0x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $3.3B XXX $3.3B XXX XXX XXX
EV (current) $4.2B XXX $4.2B XXX XXX XXX
EV/Revenue 0.5x XXX 0.5x XXX XXX XXX
EV/EBITDA 11.0x XXX 12.0x XXX XXX XXX
EV/EBIT 14.2x XXX 15.0x XXX XXX XXX
EV/Gross Profit 5.8x XXX n/a XXX XXX XXX
P/E 20.0x XXX 22.1x XXX XXX XXX
EV/FCF 29.3x XXX 21.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Ebos Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Ebos Group Margins & Growth Rates

Ebos Group's last 12 month revenue growth is 8%

Ebos Group's revenue per employee in the last FY averaged $1.3M, while opex per employee averaged $0.1M for the same period.

Ebos Group's rule of 40 is 12% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Ebos Group's rule of X is 24% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Ebos Group and other 15K+ public comps

Ebos Group Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 8% XXX 5% XXX XXX XXX
EBITDA Margin 5% XXX 4% XXX XXX XXX
EBITDA Growth 8% XXX 9% XXX XXX XXX
Rule of 40 12% XXX 12% XXX XXX XXX
Bessemer Rule of X XXX XXX 24% XXX XXX XXX
Revenue per Employee XXX XXX $1.3M XXX XXX XXX
Opex per Employee XXX XXX $0.1M XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 10% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Ebos Group Public Comps

See public comps and valuation multiples for Pharmacies comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Sigma Healthcare XXX XXX XXX XXX XXX XXX
MedPlus India XXX XXX XXX XXX XXX XXX
SC Ropharma XXX XXX XXX XXX XXX XXX
Brasil Pharma XXX XXX XXX XXX XXX XXX
D1000 Varejo Farma XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Ebos Group M&A and Investment Activity

Ebos Group acquired  XXX companies to date.

Last acquisition by Ebos Group was  XXXXXXXX, XXXXX XXXXX XXXXXX . Ebos Group acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Ebos Group

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Ebos Group

When was Ebos Group founded? Ebos Group was founded in 1922.
Where is Ebos Group headquartered? Ebos Group is headquartered in New Zealand.
How many employees does Ebos Group have? As of today, Ebos Group has 5.8K+ employees.
Is Ebos Group publicy listed? Yes, Ebos Group is a public company listed on NZE.
What is the stock symbol of Ebos Group? Ebos Group trades under EBO ticker.
When did Ebos Group go public? Ebos Group went public in 1960.
Who are competitors of Ebos Group? Similar companies to Ebos Group include e.g. Sigma Healthcare, MedPlus India, SC Ropharma, Brasil Pharma.
What is the current market cap of Ebos Group? Ebos Group's current market cap is $3.3B
What is the current revenue of Ebos Group? Ebos Group's last 12 months revenue is $9.1B.
What is the current revenue growth of Ebos Group? Ebos Group revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Ebos Group? Current revenue multiple of Ebos Group is 0.5x.
Is Ebos Group profitable? Yes, Ebos Group is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Ebos Group? Ebos Group's last 12 months EBITDA is $435M.
What is Ebos Group's EBITDA margin? Ebos Group's last 12 months EBITDA margin is 5%.
What is the current EV/EBITDA multiple of Ebos Group? Current EBITDA multiple of Ebos Group is 11.0x.
What is the current FCF of Ebos Group? Ebos Group's last 12 months FCF is $164M.
What is Ebos Group's FCF margin? Ebos Group's last 12 months FCF margin is 2%.
What is the current EV/FCF multiple of Ebos Group? Current FCF multiple of Ebos Group is 29.3x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.